Authors:
SCHWARTSMANN G
HOROWITZ M
DILEONE L
SANDER E
CAMPOS O
FERREIRA AF
SCHUNEMANN H
VIEGAS MAV
CANCELA AI
MANS DRA
Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 651-651
Authors:
SCHWARTSMANN G
DILEONE L
CALDAS APF
CAMPOS O
CANCELA AI
VIEGAS MAV
MANS DRA
Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF LOW-DOSE, 3-TIMES DAILY ORAL ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 660-660
Authors:
SCHWARTSMANN G
MANS DRA
DILEONE L
CALDAS APF
CAMPOS O
SANDER E
BORTOLINI M
VIEGAS MAV
CANCELA AI
Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE GIVEN 3-TIMES DAILY ORALLY TO PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 252-252
Authors:
SCHWARTSMANN G
HOROWITZ M
DILEONE L
SANDER E
CAMPOS O
FERREIRA AF
SCHUNEMANN H
VIEGAS MAV
CANCELA AI
MANS DRA
Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 420-420
Authors:
SCHWARTSMANN G
FERNANDES MS
SCHAAN MD
MOSCHEN M
GERHARDT LM
DILEONE L
LOITZEMBAUER B
KALAKUN L
Citation: G. Schwartsmann et al., DECITABINE (5-AZA-2'-DEOXYCYTIDINE, DAC) PLUS DAUNORUBICIN AS A FIRSTLINE TREATMENT IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA - PRELIMINARY-OBSERVATIONS, Leukemia, 11, 1997, pp. 28-31
Authors:
SCHWARTSMANN G
SPRINZ E
KROMFIELD M
KALAKUN L
SANDER E
PROLLA G
DILEONE L
GERHARDT L
MANS DRA
Citation: G. Schwartsmann et al., CLINICAL AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE IN PATIENTS WITHAIDS-RELATED KAPOSIS-SARCOMA WITH NO PRIOR EXPOSURE TO CYTOTOXIC THERAPY, Journal of clinical oncology, 15(5), 1997, pp. 2118-2124